Nanobiosystem Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
8
Nanobiosystem General Information
Description
Developer of advanced regenerative medical devices and biotechnology products designed for human tissue restoration. The company's technology utilizes extracellular matrix simulation, nanoregenerative scaffold technology, and high-precision particle technology, providing the healthcare and aesthetic sectors with absorbable tissue regeneration guides, eardrum regeneration patches, and bone regeneration guides to restore damaged human tissues to their original state using biomimetic scaffolds.
Contact Information
Website
www.nanobiosystem.co.krCorporate Office
- 43-22, Room 1820, Building A
- Cheomdangwagi-ro, 208Beon-gil, Buk-gu
- Gwangju, Jeollanam
- South Korea
Corporate Office
- 43-22, Room 1820, Building A
- Cheomdangwagi-ro, 208Beon-gil, Buk-gu
- Gwangju, Jeollanam
- South Korea
Nanobiosystem Timeline
Nanobiosystem Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 09-Sep-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 07-Nov-2023 | Completed | Startup | |||
| 3. Later Stage VC (Series A) | 17-Aug-2023 | Completed | Startup | |||
| 2. Later Stage VC | 28-Dec-2022 | $2.3M | $2.3M | Completed | Startup | |
| 1. Seed Round | 07-Nov-2017 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nanobiosystem Patents
Nanobiosystem Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026116816-A1 | System and method for manufacturing skin regeneration patch assembly | Pending | 27-Nov-2024 | ||
| WO-2026071526-A1 | Skin regeneration patch assembly and manufacturing method therefor | Pending | 24-Sep-2024 | ||
| WO-2025174205-A1 | Eardrum regeneration patch | Pending | 14-Feb-2024 | ||
| WO-2025174205-A9 | Eardrum regeneration patch | Pending | 14-Feb-2024 | ||
| US-20250169957-A1 | Cartilage regeneration scaffold and preparing method for the same | Pending | 28-Nov-2023 | A61L27/18 |
Nanobiosystem Signals
Nanobiosystem Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| IBK Changgong | Accelerator/Incubator | |||
| Tech Incubator Program for Startup | Accelerator/Incubator | |||
| 365mc | Corporation | Minority | ||
| Meritz Securities | Investment Bank | Minority | ||
| Mira Ventures | Venture Capital | Minority |
Nanobiosystem FAQs
-
When was Nanobiosystem founded?
Nanobiosystem was founded in 2017.
-
Where is Nanobiosystem headquartered?
Nanobiosystem is headquartered in Gwangju, South Korea.
-
What is the size of Nanobiosystem?
Nanobiosystem has 20 total employees.
-
What industry is Nanobiosystem in?
Nanobiosystem’s primary industry is Drug Discovery.
-
Is Nanobiosystem a private or public company?
Nanobiosystem is a Private company.
-
What is Nanobiosystem’s current revenue?
The current revenue for Nanobiosystem is .
-
How much funding has Nanobiosystem raised over time?
Nanobiosystem has raised $37.4M.
-
Who are Nanobiosystem’s investors?
IBK Changgong, Tech Incubator Program for Startup, 365mc, Meritz Securities, and Mira Ventures are 5 of 8 investors who have invested in Nanobiosystem.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process